日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Stochastic Evolutionary Control in Heterogeneous Populations

异质群体中的随机进化控制

Chen, Peng; Asher Pachter, Jonathan; Scott, Jacob G; Hinczewski, Michael

Preclinical Efficacy of the Estrogen Receptor Degrader Fulvestrant in Combination with RAF/MEK Clamp Avutometinib and FAK Inhibitor in a Low-Grade Serous Ovarian Cancer Animal Model with Acquired Resistance to Chemotherapy and Aromatase Inhibitor

雌激素受体降解剂氟维司群联合 RAF/MEK 钳制剂阿伐替尼和 FAK 抑制剂治疗对化疗和芳香化酶抑制剂产生耐药性的低级别浆液性卵巢癌动物模型的临床前疗效

Demirkiran, Cem; Bellone, Stefania; Ettorre, Victoria M; Mansolf, Miranda; Hartwich, Tobias Max Philipp; McNamara, Blair; Greenman, Michelle; Yang-Hartwich, Yang; Ratner, Elena; Santin, Niccoló G; Sethi, Namrata; Palmieri, Luca; Coma, Silvia; Pachter, Jonathan A; Ottum, Sarah; Santin, Alessandro D

Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy

基质重编程克服了对RAS-MAPK抑制剂的耐药性,从而改善了胰腺癌对细胞毒性药物和免疫疗法的反应。

Liu, Xiuting; Baer, John M; Stone, Meredith L; Knolhoff, Brett L; Hogg, Graham D; Turner, Madeleine C; Kao, Yu-Lan; Weinstein, Alyssa G; Ahmad, Faiz; Chen, Jie; Schmidt, Andrew D; Klomp, Jeffrey A; Coho, Heather; Coho, Kayjana S; Coma, Silvia; Pachter, Jonathan A; Bryant, Kirsten L; Kang, Liang-I; Lim, Kian-Huat; Beatty, Gregory L; DeNardo, David G

Early path dominance as a principle for neurodevelopment

早期通路优势作为神经发育原则

Razban, Rostam M; Pachter, Jonathan Asher; Dill, Ken A; Mujica-Parodi, Lilianne R

Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial

Duvelisib治疗2019冠状病毒病危重患者:一项研究者发起的随机、安慰剂对照、双盲试点试验

Goldsmith, Scott R; Covut, Fahrettin; Fiala, Mark; Xiang, Zhifu; Iqbal, Zahid; Moore, Nathan; Bradtke, Elizabeth; Christen, Brandon; Rettig, Michael P; Christ, Stephanie; Gehrs, Leah; Street, Emily; Wallace, Nicholas; Ritchey, Julie; Gao, Feng; Pachter, Jonathan; Parikh, Bijal; Dubberke, Erik R; DiPersio, John F

Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy

双重基质靶向治疗可增强胰腺腺癌对程序性细胞死亡蛋白1抑制剂的敏感性

Blair, Alex B; Wang, Jianxin; Davelaar, John; Baker, Andrew; Li, Keyu; Niu, Nan; Wang, Junke; Shao, Yingkuan; Funes, Vanessa; Li, Pan; Pachter, Jonathan A; Maneval, Daniel C; Dezem, Felipe; Plummer, Jasmine; Chan, Keith Syson; Gong, Jun; Hendifar, Andrew E; Pandol, Stephen J; Burkhart, Richard; Zhang, Yuqing; Zheng, Lei; Osipov, Arsen

Review of the application of Kirchhoff's Laws of series and parallel flows to pharmacology: Defining organ clearance

基尔霍夫串联和并联流动定律在药理学中的应用综述:定义器官清除率

Pachter, Jonathan Asher; Dill, Ken A; Sodhi, Jasleen K; Benet, Leslie Z

PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma

PYK2/FAK抑制剂可逆转多发性骨髓瘤中缺氧诱导的耐药性

Muz, Barbara; Buggio, Maurizio; Azab, Feda; de la Puente, Pilar; Fiala, Mark; Padval, Mahesh V; Weaver, David T; Pachter, Jonathan A; Vij, Ravi; Azab, Abdel Kareem

Focal Adhesion Kinase as a Potential Target in AML and MDS

局灶性黏着斑激酶作为急性髓系白血病和骨髓增生异常综合征的潜在治疗靶点。

Carter, Bing Z; Mak, Po Yee; Wang, Xiangmeng; Yang, Hui; Garcia-Manero, Guillermo; Mak, Duncan H; Mu, Hong; Ruvolo, Vivian R; Qiu, Yihua; Coombes, Kevin; Zhang, Nianxiang; Ragon, Brittany; Weaver, David T; Pachter, Jonathan A; Kornblau, Steven; Andreeff, Michael

The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma

细胞外基质和黏着斑激酶信号通路调控胰腺导管腺癌中的癌症干细胞功能

Begum, Asma; Ewachiw, Theodore; Jung, Clinton; Huang, Ally; Norberg, K Jessica; Marchionni, Luigi; McMillan, Ross; Penchev, Vesselin; Rajeshkumar, N V; Maitra, Anirban; Wood, Laura; Wang, Chenguang; Wolfgang, Christopher; DeJesus-Acosta, Ana; Laheru, Daniel; Shapiro, Irina M; Padval, Mahesh; Pachter, Jonathan A; Weaver, David T; Rasheed, Zeshaan A; Matsui, William